Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT

Quince Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.42 -1.25 -0.41 -4.17
PEG Ratio
-0.03 0.03 0.01 -0.27
PS Ratio
n/a n/a n/a n/a
PB Ratio
2.68 0.46 0.21 3.16
P/FCF Ratio
-2.52 -2.12 -0.48 -5.94
P/OCF Ratio
-2.54 -2.14 -0.48 -5.96
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.49 0.16 0.00 0.01
Quick Ratio
6.05 8.09 30.55 7.85
Current Ratio
6.05 8.09 30.55 7.85
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -91.58 n/a
Return on Equity
-1.89 -0.37 -0.51 -0.76
Return on Assets
-0.5 -0.19 -0.5 -0.68
Return on Invested Capital
-0.53 -0.22 -0.51 -0.75
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a